The nation of Zimbabwe has rejected a significant American health deal valued at 367 million US dollars (£272m) over five years due to the United States' demand for sensitive information.
This move was revealed following a government memo from December was disclosed, indicating that President Emmerson Mnangagwa believed the arrangement was "lopsided".
An official representative has since clarified that the United States was seeking biological samples for scientific study and commercial gain but was not willing to guarantee the resulting advantages from future treatments.
"We will now turn to the challenging and unfortunate process of scaling back our health aid in Zimbabwe," remarked US ambassador to Zimbabwe Pamela Tremont in a statement.
Her embassy said the US had furnished over $1.9bn as health assistance to Zimbabwe during the past twenty years.
A physicians' group in Zimbabwe has appealed for further negotiations to reach a agreement suitable to both sides so the country's vital HIV programme can proceed.
Broader Context
This development follows a similar situation in neighbouring Kenya, where a court halted a similar deal with the US following legal challenges were filed about the safety of citizens' health data.
After resuming the presidency recently, US President Donald Trump has slashed foreign aid and closed the US Agency for International Development (USAID).
The agency had overseen assistance for the US government, but Trump argued its spending was "inefficient" and his government was pursuing government-to-government agreements to enhance transparency and accountability.
As per reports, 16 African countries have so far signed similar health pacts, representing over $18.3bn in new funding.
Details of the Rejected Agreement
The funds for Zimbabwe was intended to funded "tackling HIV/Aids, tuberculosis, malaria, maternal and child health, and preparing for epidemics".
"We are confident this partnership might have yielded extraordinary benefits for the people of Zimbabwe, especially the 1.2 million men, women and children presently on antiretroviral therapy through American-funded initiatives," the Ambassador commented.
However, government spokesperson Nick Mangwana said the proposed deal was "unequal".
"The proposal required Zimbabwe to share its genetic material and health information indefinitely, with no corresponding guarantee of benefiting from any medical innovations – like vaccines, diagnostics, or treatments – that could result from that shared data," his statement read.
"Effectively, our country would supply the raw materials for medical research without any assurance that the final treatments would be available to our citizens should a new health crisis emerge."
National Interest and Global Health
He also pointed out that the US's withdrawal from the World Health Organization (WHO) and its pursuit of bilateral deals were undermining structures previously established through the global organization.
The spokesperson cited its Pathogen Access and Benefit Sharing framework designed to deal with future global health emergencies.
"This mechanism is intended to guarantee that when a nation contributes its samples, the resulting advantages – such as vaccines and treatments – are distributed fairly, not commercialised solely by those with the capability to create them."
The government's concerns over the US deal "are not meant as hostility towards the US," he added.
"We encourage further discussions with our American counterparts on how future collaboration might be designed in a way that respects the sovereignty and dignity of both nations."
Medical Community Reaction
A leading public health body expressed it understood the official position, but recommended that negotiations should continue given that much of the nation's Aids initiatives were funded by foreign aid.
"Where specific concerns arise, such as those relating to data governance or agreement terms, these can frequently be resolved through detailed discussion and negotiated safeguards," the group added.
This impasse highlights the ongoing tensions between receiving much-needed foreign assistance and safeguarding a country's data in an increasingly interconnected world.